Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers
暂无分享,去创建一个
[1] D. Reeves,et al. In-vitro studies with ciprofloxacin, a new 4-quinolone compound. , 1984, The Journal of antimicrobial chemotherapy.
[2] F. Roquet,et al. Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humans , 1984, Antimicrobial Agents and Chemotherapy.
[3] R. Wise,et al. The pharmacokinetics and tissue penetration of norfloxacin. , 1984, The Journal of antimicrobial chemotherapy.
[4] R. Wise,et al. Pharmacokinetics and tissue penetration of ciprofloxacin , 1983, Antimicrobial Agents and Chemotherapy.
[5] R. Fass. In vitro activity of ciprofloxacin (Bay o 9867) , 1983, Antimicrobial Agents and Chemotherapy.
[6] R. Wise,et al. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents , 1983, Antimicrobial Agents and Chemotherapy.
[7] D. van der Waaij. Colonization resistance of the digestive tract: clinical consequences and implications. , 1982, The Journal of antimicrobial chemotherapy.
[8] J. Hamilton-miller,et al. Rifaprim (rifampicin plus trimethoprim): pharmacokinetics and effects on the normal flora of man. , 1981, Biopharmaceutics & drug disposition.
[9] W. Ryan. Cowan and Steel's Manual for the Identification of Medical Bacteria, 2nd Edition , 1975 .
[10] J. Crowther. Transport and storage of faeces for bacteriological examination. , 1971, The Journal of applied bacteriology.